In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
In the latest session, Compass Therapeutics Inc (NASDAQ: CMPX) closed at $2.92 down -5.19% from its previous closing price of $3.08. In other words, the price has decreased by -$5.19 from its previous closing price. On the day, 1.13 million shares were traded.
Ratios:
For a deeper understanding of Compass Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 31.84 and its Current Ratio is at 31.84. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on February 19, 2025, initiated with a Overweight rating and assigned the stock a target price of $12.
On December 23, 2024, D. Boral Capital started tracking the stock assigning a Buy rating and target price of $32.
Leerink Partners Downgraded its Outperform to Market Perform on November 15, 2024, whereas the target price for the stock was revised from $5 to $4.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 472.66 while its Price-to-Book (P/B) ratio in mrq is 2.90.
Stock Price History:
Over the past 52 weeks, CMPX has reached a high of $4.08, while it has fallen to a 52-week low of $0.76. The 50-Day Moving Average of the stock is 22.80%, while the 200-Day Moving Average is calculated to be 75.50%.
Shares Statistics:
A total of 137.59M shares are outstanding, with a floating share count of 80.27M. Insiders hold about 41.66% of the company’s shares, while institutions hold 39.07% stake in the company.
